Group 1 - The company confirms that its development in the pharmaceutical sector, particularly in high-end raw materials and formulations, is in line with the annual planning expectations [2] - The company has completed the preparation of kilogram-level sulfide electrolyte precursors and electrolyte samples, and is currently optimizing testing for solid electrolytes while preparing for pilot line construction [2]